EMA Authorised: Rotarix (human rotavirus, live attenuated) — GlaxoSmithKline Biologicals S.A.

View source ↗

Summary

Rotarix (human rotavirus, live attenuated) by GlaxoSmithKline Biologicals S.A. has been authorised by the EMA for immunization against rotavirus infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunization
• Rotavirus Infections

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Status: Authorised. Therapeutic area: Immunization;Rotavirus Infections. MAH: GlaxoSmithKline Biologicals S.A.. Decision date: 23/07/2026